Table 2

Univariate analysis of prognostic factors for overall survival and progression-free survival

Patient characteristics	5-year OS (%)	P values	5-year PFS (%)	P values
Patient age
<60 years	42	0.1	40	0.1
≥60 years	29		28
Pathology
Endometrioid	40	0.002	38	0.005
Non-endometrioid	21		21
LVSI
Absent	54	0.6	52	0.5
Present	32		29
Myometrial invasion
<50%	64	0.02	56	0.02
≥50%	30		29
Grade
I-II	47	<0.001	45	<0.001
III	24		23
No of PA ln metastasis
1	46	0.06	42	0.1
>1	26		26
Cuff BRT
Absent	34	0.6	38	0.4
Present	36		30
Treatment
RT	16	<0.001	16	<0.001
RT +ChT	46		44

BRT, brachytherapy; ChT, chemotherapy; LVSI, lymphovascular space invasion; OS, overall survival; PA, paraaortic; PFS, progression free survival; RT, radiotherapy.